What is Typical Treatment?

Three standard treatments exist for brain tumours:

  • Surgery
  • Radiation therapy
  • Chemotherapy

Depending on the type of tumour, an observation approach is often used to monitor for any changes in the tumour. This is done wtih a series of scheduled MRIs or CT scans.

Treatment plans are individualized to the patient, and the type and grade of tumour.

Patients are usually followed by a variety of health care providers including oncologists, neuro-oncologists, neurologists and/or neurosurgeons.

Surgery

Often surgery is the first treatment offered if the tumour is in an operable area. If surgery is not an option, a biopsy may be ordered.

The goal of surgery is to remove or de-bulk as much tumour as possible, and get an accurate diagnosis by the pathologist.
 

Surgery may include:

  • Brain tumour biopsy: to help determine the type of brain tumour
  • Brain tumour resection: The goal of a brain tumour resection is to remove as much of a brain tumour as safely as possible.
    • Removing all (gross total) or part of (sub-total) of a brain tumour might help to reduce symptoms that a patient has.
    • Determining to do a biopsy vs. resection depends on the location, size and type of tumour and symptoms. Sometimes age and health will also determine the decision.

Recent advances in brain surgery include:

  • Awake craniotomy: has helped and continues to help with mapping the brain
  • Having the patient reading and/or talking at the same time
  • These advances have added complexity and time to surgery 
     

Radiation Therapy

Radiation therapy involves administering high levels of radiation directly at a tumour. Standard radiation therapy lasts for 6 weeks, Monday to Friday for 30 treatments. Sub-types of Radiation Therapy are:

Stereotactic Radiosurgery is given in one single treatment.

  •  
  •  
  •  

Gamma Knife is used to treat meningiomas, pituitary tumours, acoustic neuromas, and secondary tumours.

  •  
  • (A diagram of Gamma Knife process is pictured at left)
     

 

 

 


 

Chemotherapy

Chemotherapy is the use of medication to stop or slow the growth of tumour cells. It is often given orally or intravenously.

Temodal® (or Temozolomide) is a common chemotherapy drug for brain tumour patients. It is often given concurrently with radiation therapy for high-grade gliomas. Find out more about Temodal with this Information Sheet.

Avastin®

Avastin® (Bevacizumab) is the first and only biologic treatment approved by Health Canada for recurrent glioblastoma multiforme (GBM), which offers an additional treatment option for people with the disease. Find out more about Avastin with this Information Sheet.

 

Share This

Featured Story

Piper's Story: a dream more precious than Olympic gold

Hi, I am Piper Gilles. You may know me as a world-famous ice dancer. I competed in the PyeongChang 2018 Olympic Winter Games. I am a 7 time world team member and a 7 time Canadian medalist. But the title that means the most to me is far more personal. It’s that of daughter to my amazing mother Bonnie Gilles, who I lost to glioblastoma on May 27, 2018.

Learn more

Spotlight

Doug's Adventure

I am Doug, I have brain cancer; I am told it is terminal, but the “good” kind of terminal. I can assure you that receiving that news...

Learn more

Kathy's Volunteer Profile

Kathy shares her story of volunteering for Brain Tumour Foundation of Canada as part of National Volunteer Week. “I am proud and happy...

Learn more

Upcoming Events

  • 27/Jun/2019: Virtual Support Group East: Virtual Support Group for Eastern Canada... Learn more >
  • 27/Jun/2019: Sarnia Support Group: Meets at St. Giles Presbyterian Church,770 Lakeshore Road Sarnia, ON... Learn more >
  • 30/Jun/2019: Annual BBQ: Pakenham, ON... Learn more >
  • 02/Jul/2019: London Support Group: Meets at First Baptist Church, 568 Richmond Street, London, ON... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2019 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001